{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:16:52Z","timestamp":1783131412944,"version":"3.54.6"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32030060"],"award-info":[{"award-number":["32030060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430067"],"award-info":[{"award-number":["82430067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L258028"],"award-info":[{"award-number":["L258028"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007056","name":"National Nanotechnology Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1201000"],"award-info":[{"award-number":["2021YFA1201000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2605000"],"award-info":[{"award-number":["2023YFC2605000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejpb.2026.115089","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:08:08Z","timestamp":1777129688000},"page":"115089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cationic nanolipoplexes for high-performance mRNA transfection at the nasal mucosa"],"prefix":"10.1016","volume":"224","author":[{"given":"Piroonrat","family":"Dechbumroong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarawut","family":"Lapmanee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-9514","authenticated-orcid":false,"given":"Wisawat","family":"Keaswejjareansuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thunyatorn","family":"Yimsoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worapapar","family":"Treesuppharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apipu","family":"Ariyachayut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Jie","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katawut","family":"Namdee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3892-5100","authenticated-orcid":false,"given":"Mengliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0005","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41541-023-00773-0","article-title":"Outlook of pandemic preparedness in a post-COVID-19 world","volume":"8","author":"Williams","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"10","key":"10.1016\/j.ejpb.2026.115089_b0010","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S1473-3099(14)70899-0","article-title":"Emerging respiratory tract infections","volume":"14","author":"Zumla","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115089_b0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0020","article-title":"Exploring precision treatments in immune-mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid delivery","volume":"5","author":"Xu","year":"2025","journal-title":"Exploration (beijing)"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115089_b0025","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1007\/s12274-021-3832-y","article-title":"Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform","volume":"15","author":"Sa-Nguanmoo","year":"2022","journal-title":"Nano Res."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115089_b0030","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115089_b0035","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/cea.13874","article-title":"Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer\/BioNTech mRNA COVID-19 vaccine","volume":"51","author":"Sellaturay","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.ejpb.2026.115089_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2023.1056619","article-title":"Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization","volume":"4","author":"AlOtaibi","year":"2023","journal-title":"Front. Allergy"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115089_b0045","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of Anaphylaxis after Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0050","article-title":"Public fear of COVID-19 vaccines in Iraqi Kurdistan region: a cross-sectional study. Middle East current","volume":"28","author":"Tahir","year":"2021","journal-title":"Psychiatry"},{"key":"10.1016\/j.ejpb.2026.115089_b0055","article-title":"Perception and willingness toward various immunization routes for COVID-19 vaccines: a cross-sectional survey in China","volume":"11","author":"Wang","year":"2023","journal-title":"Front. Public Health"},{"issue":"52","key":"10.1016\/j.ejpb.2026.115089_b0060","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1016\/j.vaccine.2022.10.026","article-title":"Prevalence of pain and fear as barriers to vaccination in children \u2013 Systematic review and meta-analysis","volume":"40","author":"Taddio","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.ejpb.2026.115089_b0065","doi-asserted-by":"crossref","DOI":"10.1177\/21501327211007393","article-title":"Considering Needle Phobia among Adult patients during Mass COVID-19 Vaccinations","volume":"12","author":"Love","year":"2021","journal-title":"J. Prim. Care Community Health"},{"key":"10.1016\/j.ejpb.2026.115089_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104402","article-title":"SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination","volume":"87","author":"Liew","year":"2023","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115089_b0075","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","article-title":"Intranasal drug delivery: opportunities and toxicologic challenges during drug development","volume":"12","author":"Keller","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115089_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120686","article-title":"Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?","volume":"603","author":"Tiboni","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115089_b0085","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejpb.2026.115089_b0090","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez-S\u00e1nchez, M., et al., Two MP2CL5 antigen vaccines from Naegleria fowleri stimulate the immune response against meningitis in the BALB\/c model. Infection and Immunity, 2023. 91((7)): p. e00181-23.","DOI":"10.1128\/iai.00181-23"},{"issue":"10","key":"10.1016\/j.ejpb.2026.115089_b0095","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/infdis\/jiz352","article-title":"Intranasal Vaccination with Multiple Virulence Factors Promotes Mucosal Clearance of Streptococcus suis across Serotypes and Protects against Meningitis in mice","volume":"220","author":"Xing","year":"2019","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.ejpb.2026.115089_b0100","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.imbio.2018.07.021","article-title":"Evaluation of intranasal and subcutaneous route of immunization in neonatal mice using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria meningitis B","volume":"223","author":"de Oliveira Santos","year":"2018","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41541-024-00857-5","article-title":"An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza","volume":"9","author":"Xing","year":"2024","journal-title":"npj Vaccines"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41541-022-00478-w","article-title":"Rational development of a combined mRNA vaccine against COVID-19 and influenza","volume":"7","author":"Ye","year":"2022","journal-title":"npj Vaccines"},{"issue":"50","key":"10.1016\/j.ejpb.2026.115089_b0115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109744118","article-title":"A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters","volume":"118","author":"Liu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115089_b0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.14639\/0392-100X-N0357","article-title":"Effects of liposomal nasal spray with vitamins a and E on allergic rhinitis","volume":"40","author":"Lauriello","year":"2020","journal-title":"Acta Otorhinolaryngol. Ital."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0125","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejpb.2007.12.001","article-title":"Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier","volume":"69","author":"Jain","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115089_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118584","article-title":"Improving the hypoglycemic effect of insulin via the nasal administration of deep eutectic solvents","volume":"569","author":"Li","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0135","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41598-019-39191-5","article-title":"Distribution of insulin in trigeminal nerve and brain after intranasal administration","volume":"9","author":"Lochhead","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.afos.2020.02.001","article-title":"Association between elcatonin use and cancer risk in Japan: a follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis","volume":"6","author":"Okamoto","year":"2020","journal-title":"Osteoporos Sarcopenia"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40001-021-00610-x","article-title":"A meta-analysis of the therapeutic effect of intranasal salmon calcitonin on osteoporosis","volume":"26","author":"Li","year":"2021","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jconrel.2004.08.001","article-title":"Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer\/glutathione microparticulate delivery system","volume":"100","author":"Leitner","year":"2004","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115089_b0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2009.05.057","article-title":"Direct nose-to-brain transfer of a growth hormone releasing neuropeptide, hexarelin after intranasal administration to rabbits","volume":"378","author":"Yu","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2012.06.014","article-title":"CriticalSorb: a novel efficient nasal delivery system for human growth hormone based on Solutol HS15","volume":"162","author":"Illum","year":"2012","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115089_b0165","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1210\/jc.2014-4146","article-title":"Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable with Subcutaneous Injection with lower Systemic Exposure to hGH in healthy Volunteers","volume":"100","author":"Lewis","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115089_b0170","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/PEC.0000000000001556","article-title":"Analgesic efficacy of intranasal ketamine versus intranasal fentanyl for moderate to severe pain in children: a prospective, randomized, double-blind study","volume":"37","author":"Quinn","year":"2021","journal-title":"Pediatr. Emerg. Care"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115089_b0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annemergmed.2014.09.024","article-title":"The PICHFORK (Pain in Children Fentanyl or Ketamine) trial: a randomized controlled trial comparing intranasal ketamine and fentanyl for the relief of moderate to severe pain in children with limb injuries","volume":"65","author":"Graudins","year":"2015","journal-title":"Ann. Emerg. Med."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115089_b0180","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/acem.13313","article-title":"Randomized Controlled Feasibility Trial of Intranasal Ketamine Compared to Intranasal Fentanyl for Analgesia in Children with Suspected Extremity Fractures","volume":"24","author":"Reynolds","year":"2017","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.ejpb.2026.115089_b0185","doi-asserted-by":"crossref","first-page":"41768","DOI":"10.1038\/srep41768","article-title":"Intranasal delivery of a Novel Amnion Cell Secretome Prevents Neuronal damage and Preserves Function In a Mouse Multiple Sclerosis Model","volume":"7","author":"Khan","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/WNO.0000000000000760","article-title":"Effects of Varying Intranasal Treatment Regimens in ST266-Mediated Retinal Ganglion Cell Neuroprotection","volume":"39","author":"Khan","year":"2019","journal-title":"J. Neuroophthalmol."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0195","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00431-019-03519-0","article-title":"Intranasal treatment of vitamin B(12) deficiency in children","volume":"179","author":"Estourgie-van Burk","year":"2020","journal-title":"Eur. J. Pediatr."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115089_b0200","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/bcp.16084","article-title":"Intranasal vitamin B(12) administration in elderly patients: a randomized controlled comparison of two dosage regimens","volume":"90","author":"Tillemans","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0210","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13346-021-00940-7","article-title":"Intranasal drug delivery for treatment of Alzheimer's disease","volume":"11","author":"Fonseca","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0215","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/acsnano.1c08473","article-title":"Intranasal Administration of Self-Oriented Nanocarriers Based on Therapeutic Exosomes for Synergistic Treatment of Parkinson's Disease","volume":"16","author":"Peng","year":"2022","journal-title":"ACS Nano"},{"issue":"43","key":"10.1016\/j.ejpb.2026.115089_b0220","doi-asserted-by":"crossref","first-page":"12773","DOI":"10.1021\/acs.langmuir.0c02410","article-title":"Mucin Biopolymers and their Barrier Function at Airway Surfaces","volume":"36","author":"Song","year":"2020","journal-title":"Langmuir"},{"issue":"13","key":"10.1016\/j.ejpb.2026.115089_b0225","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.biomaterials.2013.01.064","article-title":"Nanoparticle diffusion in respiratory mucus from humans without lung disease","volume":"34","author":"Schuster","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2026.115089_b0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejpb.2020.01.017","article-title":"Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer","volume":"149","author":"Alp","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115089_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121180","article-title":"Intranasal vaccine: Factors to consider in research and development","volume":"609","author":"Xu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115089_b0240","doi-asserted-by":"crossref","unstructured":"Baldeon Vaca, G., et al., Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection. Sci Adv, 2023. 9(38): p. eadh1655.","DOI":"10.1126\/sciadv.adh1655"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115089_b0245","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.tim.2021.03.014","article-title":"Respiratory mucus as a virus-host range determinant","volume":"29","author":"Wallace","year":"2021","journal-title":"Trends Microbiol."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0250","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"50","key":"10.1016\/j.ejpb.2026.115089_b0255","doi-asserted-by":"crossref","first-page":"50393","DOI":"10.1074\/jbc.M309026200","article-title":"Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport","volume":"278","author":"Dawson","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115089_b0260","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1021\/mp100242r","article-title":"Disruption of the mucus barrier by topically applied exogenous particles","volume":"7","author":"McGill","year":"2010","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0265","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115089_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120148","article-title":"Oral mucus-penetrating PEGylated liposomes to improve drug absorption: differences in the interaction mechanisms of a mucoadhesive liposome","volume":"593","author":"Yamazoe","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11095-022-03460-2","article-title":"Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid delivery","volume":"40","author":"Sun","year":"2023","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115089_b0280","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1021\/acs.molpharmaceut.0c00170","article-title":"Intranasal delivery and Transfection of mRNA Therapeutics in the Brain using Cationic Liposomes","volume":"17","author":"Dhaliwal","year":"2020","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/ph14020164","article-title":"In Vitro Characterization of Inhalable Cationic Hybrid Nanoparticles as potential Vaccine Carriers","volume":"14","author":"Alfagih","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115089_b0290","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17030329","article-title":"Effects of Surface Charge of Inhaled Liposomes on Drug Efficacy and Biocompatibility","volume":"17","author":"Zhang","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115089_b0295","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.2147\/IJN.S448005","article-title":"Lipid Nanoparticle-based Inhibitors for SARS-CoV-2 Host Cell Infection","volume":"19","author":"Yathindranath","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115089_b0300","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ejpb.2026.115089_b0305","article-title":"Liposomes for drug delivery: Classification, therapeutic applications, and limitations. next","volume":"8","author":"Chelliah","year":"2025","journal-title":"Nanotechnology"},{"issue":"Pt 2","key":"10.1016\/j.ejpb.2026.115089_b0310","article-title":"Double-layered nano vesicular chitosan-coated liposomal system loaded with donepezil cargo for Alzheimer's disease: design, optimization, and in vivo evaluation","volume":"332","author":"Abla","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115089_b0315","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/EBC20200067","article-title":"Mammalian lipids: structure, synthesis and function","volume":"65","author":"Cockcroft","year":"2021","journal-title":"Essays Biochem."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcis.2004.05.042","article-title":"Mechanical properties and stability measurement of cholesterol-containing liposome on mica by atomic force microscopy","volume":"278","author":"Liang","year":"2004","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2026.115089_b0325","first-page":"1","article-title":"Application of lipid-based nanoparticles in cancer immunotherapy","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115089_b0330","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1021\/acsomega.3c08353","article-title":"Lipid Nanoparticle-based delivery System-a competing place for mRNA Vaccines","volume":"9","author":"Zhang","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejpb.2026.115089_b0335","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jconrel.2020.06.027","article-title":"Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: the impact of cationic lipid selection","volume":"325","author":"Lou","year":"2020","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115089_b0340","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1742-7843.2011.00851.x","article-title":"Airway effects of inhaled quaternary ammonium compounds in mice","volume":"110","author":"Larsen","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejpb.2026.115089_b0345","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.colsurfb.2014.12.032","article-title":"Rational design of didodecyldimethylammonium bromide-based nanoassemblies for gene delivery","volume":"126","author":"Jin","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115089_b0350","doi-asserted-by":"crossref","DOI":"10.3390\/diseases10030046","article-title":"Immunological Effects of Dimethyldioctadecylammonium Bromide and Saponin as Adjuvants for Outer Membrane Vesicles from Neisseria meningitidis","volume":"10","author":"Correa","year":"2022","journal-title":"Diseases"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0355","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2010.07.114","article-title":"Didodecyldimethylammonium bromide (DDAB) induces caspase-mediated apoptosis in human leukemia HL-60 cells","volume":"147","author":"Kusumoto","year":"2010","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0360","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/08982100802642457","article-title":"Expression of luciferase plasmid (pCMVLuc) entrapped in DPPC\/cholesterol\/DDAB liposomes in HeLa cell lines","volume":"19","author":"Manosroi","year":"2009","journal-title":"J. Liposome Res."},{"issue":"20","key":"10.1016\/j.ejpb.2026.115089_b0365","doi-asserted-by":"crossref","DOI":"10.3390\/app9204438","article-title":"Soft Cationic Nanoparticles for Drug delivery: production and Cytotoxicity of Solid Lipid Nanoparticles (SLNs)","volume":"9","author":"Silva","year":"2019","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ejpb.2026.115089_b0370","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2017.11.013","article-title":"Towards topical microRNA-directed therapy for epidermal disorders","volume":"269","author":"Ross","year":"2018","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115089_b0375","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejpb.2014.04.001","article-title":"The surface charge of liposomal adjuvants is decisive for their interactions with the Calu-3 and A549 airway epithelial cell culture models","volume":"87","author":"Ingvarsson","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115089_b0380","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/0923-2494(92)80060-X","article-title":"DDA as an immunological adjuvant","volume":"143","author":"Hilgers","year":"1992","journal-title":"Res. Immunol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0385","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2009.10.043","article-title":"CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations","volume":"390","author":"Christensen","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115089_b0390","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10580","article-title":"Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles","volume":"8","author":"Lewis","year":"2023","journal-title":"Bioeng. Transl. Med."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0395","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12951-024-02345-3","article-title":"Inhalable hybrid nanovaccines with virus-biomimetic structure boost protective immune responses against SARS-CoV-2 variants","volume":"22","author":"Wang","year":"2024","journal-title":"J Nanobiotechnology"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115089_b0400","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/irv.12124","article-title":"Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF-10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses","volume":"7","author":"Kimoto","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"issue":"36","key":"10.1016\/j.ejpb.2026.115089_b0405","doi-asserted-by":"crossref","first-page":"18977","DOI":"10.1021\/acs.langmuir.4c01666","article-title":"Phosphatidylcholine Surface Hydration-Dependent Adsorption to Mucin Enhances Intestinal Mucus Barrier Function","volume":"40","author":"Feng","year":"2024","journal-title":"Langmuir"},{"key":"10.1016\/j.ejpb.2026.115089_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114814","article-title":"Better GRAS than sorry: Excipient toxicity in pulmonary formulations","author":"Frohlich","year":"2025","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115089_b0415","article-title":"The Role of Pulmonary Surfactants in the Treatment of Acute respiratory Distress Syndrome in COVID-19","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115089_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115111","article-title":"Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy","volume":"202","author":"Jin","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115089_b0425","doi-asserted-by":"crossref","unstructured":"Aralekallu, S., R. Boddula, and V. Singh, Development of glass-based microfluidic devices: A review on its fabrication and biologic applications. Materials & Design, 2023. 225..","DOI":"10.1016\/j.matdes.2022.111517"},{"key":"10.1016\/j.ejpb.2026.115089_b0430","article-title":"Mass production system for RNA-loaded lipid nanoparticles using piling up microfluidic devices","volume":"31","author":"Maeki","year":"2023","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.ejpb.2026.115089_b0435","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cherd.2019.11.031","article-title":"A review on novel methodologies for drug nanoparticle preparation: Microfluidic approach","volume":"153","author":"Shrimal","year":"2020","journal-title":"Chem. Eng. Res. Des."},{"key":"10.1016\/j.ejpb.2026.115089_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114197","article-title":"Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids","volume":"184","author":"Prakash","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115089_b0445","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0076-6879(09)65007-2","article-title":"Microfluidic methods for production of liposomes","volume":"465","author":"Yu","year":"2009","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejpb.2026.115089_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111369","article-title":"Improvement of the multi-performance biocharacteristics of cordycepin using BiloNiosome-core\/chitosan-shell hybrid nanocarriers","volume":"197","author":"Kengkittipat","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejpb.2026.115089_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.fsi.2023.108913","article-title":"Oral delivery of a Streptococcus agalactiae vaccine to Nile tilapia (Oreochromis niloticus) using a novel cationic-based nanoemulsion containing bile salts","volume":"139","author":"Suwanbumrung","year":"2023","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.ejpb.2026.115089_b0460","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.ph.57.030195.003223","article-title":"Mucin biophysics","volume":"57","author":"Bansil","year":"1995","journal-title":"Annu. Rev. Physiol."},{"issue":"23","key":"10.1016\/j.ejpb.2026.115089_b0465","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202315128","article-title":"Dual Barrier\u2010Penetrating Inhaled Nanoparticles for Enhanced Idiopathic Pulmonary Fibrosis Therapy","volume":"34","author":"Yang","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115089_b0470","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41565-023-01580-3","article-title":"Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity","volume":"19","author":"Liu","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejpb.2026.115089_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106935","article-title":"Preparation, physicochemical characterization, ex vivo, and in vivo evaluations of asiatic acid-loaded solid lipid nanoparticles formulated with natural waxes for nose-to-brain delivery","volume":"203","author":"Rojanaratha","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115089_b0480","article-title":"A perspective of lipid nanoparticles for RNA delivery","volume":"4","author":"Ma","year":"2024","journal-title":"Exploration (beijing)"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0485","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-2836(83)80007-2","article-title":"Lipid bilayer thickness varies linearly with acyl chain length in fluid phosphatidylcholine vesicles","volume":"166","author":"Lewis","year":"1983","journal-title":"J. Mol. Biol."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115089_b0490","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1021\/bi00386a007","article-title":"Mixed-chain phosphatidylcholine bilayers: structure and properties","volume":"26","author":"Mattai","year":"1987","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115089_b0495","first-page":"159","article-title":"Structure of lipid bilayers. Biochimica et Biophysica Acta (BBA)-Reviews on","volume":"1469","author":"Nagle","year":"2000","journal-title":"Biomembranes"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0500","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of Particle size and Polydispersity Index on the Clinical applications of Lipidic Nanocarrier Systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0505","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/s41598-020-62500-2","article-title":"Preparation of nanoliposomes by microfluidic mixing in herring-bone channel and the role of membrane fluidity in liposomes formation","volume":"10","author":"Kotoucek","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2026.115089_b0510","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.addr.2018.03.008","article-title":"Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems","volume":"128","author":"Maeki","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115089_b0515","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s11051-007-9340-5","article-title":"Preparation of nanoparticles by continuous-flow microfluidics","volume":"10","author":"Jahn","year":"2008","journal-title":"J. Nanopart. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0520","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0005-2736(78)90110-4","article-title":"The effect of cholesterol on the structure of phosphatidylcholine bilayers","volume":"513","author":"McIntosh","year":"1978","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2026.115089_b0525","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2018.09.047","article-title":"A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: from liposomal preparation to therapy","volume":"551","author":"Farzaneh","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115089_b0530","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.actbio.2023.07.059","article-title":"Immunotherapeutic treatment of lung cancer and bone metastasis with a mPLA\/mRNA tumor vaccine","volume":"169","author":"Ma","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2026.115089_b0535","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.actbio.2021.04.034","article-title":"Co-delivery of IL-12 cytokine gene and cisplatin prodrug by a polymetformin-conjugated nanosystem for lung cancer chemo-gene treatment through chemotherapy sensitization and tumor microenvironment modulation","volume":"128","author":"Sun","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2026.115089_b0540","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejpb.2022.01.009","article-title":"Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung","volume":"172","author":"Zhao","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115089_b0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015434","article-title":"Functionalized positive nanoparticles reduce mucin swelling and dispersion","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115089_b0550","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/adc.64.4.546","article-title":"Measurement of nasal mucociliary clearance","volume":"64","author":"Corbo","year":"1989","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejpb.2026.115089_b0555","doi-asserted-by":"crossref","unstructured":"Schipper, N.G., Verhoef, J. C., & Merkus, F. W. (1991). The nasal mucociliary clearance: relevance to nasal drug delivery. Pharmaceutical research, 8(7), 807-814., The Nasal Mucociliary Clearance Relevance to Nasal Drug Delivery. Pharmaceutical research, 1991. 8(7): p. 807-814.","DOI":"10.1023\/A:1015830907632"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0560","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0954-6111(94)90020-5","article-title":"The assessment of nasal mucociliary clearance and the effect of drugs","volume":"88","author":"Rusznak","year":"1994","journal-title":"Respir. Med."},{"key":"10.1016\/j.ejpb.2026.115089_b0565","unstructured":"Mahakit, P., & Pumhlrun, P. , A preliminary study of nasal mucociliary clearance in smokers, sinusitis and allergic rhinitis patients. Asian Pacific Journal of Allergy and Immunology, 13(2), 119. Asian Pacific Journal of Allergy and Immunology, 1995. 13(2): p. 119-121."},{"key":"10.1016\/j.ejpb.2026.115089_b0570","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.foodhyd.2015.12.034","article-title":"Characterization of mucin \u2013 lipid droplet interactions: Influence on potential fate of fish oil-in-water emulsions under simulated gastrointestinal conditions","volume":"56","author":"Chang","year":"2016","journal-title":"Food Hydrocoll."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0575","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11483-016-9426-7","article-title":"Encapsulation of \u03b2-carotene in Nanoemulsion-based delivery Systems formed by Spontaneous Emulsification: Influence of Lipid Composition on Stability and Bioaccessibility","volume":"11","author":"Zhang","year":"2016","journal-title":"Food Biophys."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0580","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1039\/C6FO01171C","article-title":"Oral processing of emulsion systems from a colloidal perspective","volume":"8","author":"Sarkar","year":"2017","journal-title":"Food Funct."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115089_b0585","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1039\/D0FO03180A","article-title":"Protein-saliva interactions: a systematic review","volume":"12","author":"Brown","year":"2021","journal-title":"Food Funct."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115089_b0590","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1517\/17425247.2010.488687","article-title":"Liposomes as delivery systems for nasal vaccination: strategies and outcomes","volume":"7","author":"Heurtault","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115089_b0595","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15102457","article-title":"Nanoparticle-Mediated strategies for Enhanced Drug Penetration and Retention in the Airway Mucosa","volume":"15","author":"Yan","year":"2023","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115089_b0600","doi-asserted-by":"crossref","DOI":"10.1002\/ejlt.201800039","article-title":"Comparative Effects of Cholesterol and \u03b2\u2010Sitosterol on the Liposome Membrane Characteristics","volume":"120","author":"Jovanovi\u0107","year":"2018","journal-title":"Eur. J. Lipid Sci. Technol."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115089_b0605","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1021\/la053238f","article-title":"Cationic liposomes in mixed didodecyldimethylammonium bromide and dioctadecyldimethylammonium bromide aqueous dispersions studied by differential scanning calorimetry, Nile Red fluorescence, and turbidity","volume":"22","author":"Feitosa","year":"2006","journal-title":"Langmuir"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115089_b0610","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12551-011-0057-4","article-title":"Electrostatic field effects on membrane domain segregation and on lateral diffusion","volume":"3","author":"Wilke","year":"2011","journal-title":"Biophys. Rev."},{"issue":"51","key":"10.1016\/j.ejpb.2026.115089_b0615","doi-asserted-by":"crossref","first-page":"28240","DOI":"10.1021\/jacs.3c11463","article-title":"Molecular Mechanisms of Cationic Fusogenic Liposome Interactions with Bacterial Envelopes","volume":"145","author":"Scheeder","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115089_b0620","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1021\/acsabm.5c00424","article-title":"Evaluation of mRNA Transfection Reagents for mRNA delivery and Vaccine Efficacy via Intramuscular Injection in mice","volume":"8","author":"Kim","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0625","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020410","article-title":"Safe and Effective delivery of mRNA using Modified PEI-Based Lipopolymers","volume":"15","author":"Wang","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0630","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1038\/s41598-020-60506-4","article-title":"mRNA Transfection-Induced Activation of Primary Human Monocytes and Macrophages: Dependence on Carrier System and Nucleotide Modification","volume":"10","author":"Moradian","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115089_b0635","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jconrel.2010.07.124","article-title":"mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers","volume":"147","author":"Rejman","year":"2010","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0640","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1754-1611-8-8","article-title":"Optimized conditions for successful transfection of human endothelial cells with in vitro synthesized and modified mRNA for induction of protein expression","volume":"8","author":"Avci-Adali","year":"2014","journal-title":"J. Biol. Eng."},{"issue":"22","key":"10.1016\/j.ejpb.2026.115089_b0645","doi-asserted-by":"crossref","first-page":"18102","DOI":"10.1039\/C5RA25333K","article-title":"Nanoparticles as transfection agents: a comprehensive study with ten different cell lines","volume":"6","author":"Neuhaus","year":"2016","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0650","doi-asserted-by":"crossref","DOI":"10.1186\/s41120-025-00125-3","article-title":"Impact of cell line and reporter gene selection on in-vitro transfection evaluation of mRNA lipid nanoparticles","volume":"11","author":"Zhen","year":"2025","journal-title":"AAPS Open"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115089_b0655","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0660","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","article-title":"mRNA-based therapeutics: powerful and versatile tools to combat diseases","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0665","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Control. Release"},{"issue":"14","key":"10.1016\/j.ejpb.2026.115089_b0670","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1039\/D4NR00019F","article-title":"Advances in lipid nanoparticle mRNA therapeutics beyond COVID-19 vaccines","volume":"16","author":"Wu","year":"2024","journal-title":"Nanoscale"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115089_b0675","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"issue":"1\u20133","key":"10.1016\/j.ejpb.2026.115089_b0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2012.03.006","article-title":"Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data","volume":"297","author":"Han","year":"2012","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/j.ejpb.2026.115089_b0685","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3109\/17435390.2012.739665","article-title":"An in vivo and in vitro toxicological characterisation of realistic nanoscale CeO(2) inhalation exposures","volume":"7","author":"Demokritou","year":"2013","journal-title":"Nanotoxicology"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0690","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/toxsci\/kfw087","article-title":"From the Cover: Comparative Numerical Modeling of Inhaled Nanoparticle Deposition in Human and Rat Nasal Cavities","volume":"152","author":"Dong","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejpb.2026.115089_b0695","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaerosci.2015.12.006","article-title":"Surface area is the biologically most effective dose metric for acute nanoparticle toxicity in the lung","volume":"99","author":"Schmid","year":"2016","journal-title":"J. Aerosol Sci"},{"issue":"Pt 1","key":"10.1016\/j.ejpb.2026.115089_b0700","first-page":"83","article-title":"Comparative morphometry of the nasal cavity in rats and mice","volume":"135","author":"Gross","year":"1982","journal-title":"J. Anat."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115089_b0705","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2012.03.003","article-title":"Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids","volume":"134","author":"Grassin-Delyle","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2026.115089_b0710","article-title":"Novel Methods for Intranasal Administration under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug delivery","volume":"141","author":"Kanazawa","year":"2018","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115089_b0715","first-page":"337","article-title":"Anesthesia protocols in laboratory animals used for scientific purposes","volume":"89","author":"Cicero","year":"2018","journal-title":"Acta Biomed"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115089_b0720","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1038\/s41598-021-84605-y","article-title":"Differential effect of anesthetics on mucociliary clearance in vivo in mice","volume":"11","author":"Feldman","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115089_b0725","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2020.07.024","article-title":"A Thermostable mRNA Vaccine against COVID-19","volume":"182","author":"Zhang","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115089_b0730","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1039\/D0BM01609H","article-title":"Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver","volume":"9","author":"Zhang","year":"2021","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115089_b0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031359","article-title":"Visualization of murine intranasal dosing efficiency using luminescent Francisella tularensis: effect of instillation volume and form of anesthesia","volume":"7","author":"Miller","year":"2012","journal-title":"PLoS One"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:26:27Z","timestamp":1783128387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126001104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":147,"alternative-id":["S0939641126001104"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115089","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cationic nanolipoplexes for high-performance mRNA transfection at the nasal mucosa","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115089"}}